Pharmstandard posts 1H 2009 Net Profit of 2.59 billion Roubles
Published: 01 September, 2009, 11:35
The leading Russian pharmaceutical company, Pharmstandard has posted a 1H 2009 Net Profit of 2.59 billion Roubles under IFRS.
breakingnews
01.09.2009, 10:32
1 comment
Russian private schools, including those oldest and most distinguished, have slashed fees for families hit by the economic crisis.
Russia’s pharmaceutical industry needs modernisation, but even the President admits it’s a serious challenge needing private capital, while visiting a new research center.
31.08.2009, 15:31
2 comments
Nargiz Asadova from Kommersant Newspaper and Andrey Komarov from management consultancy PricewaterhouseCoopers discuss the Russian car production slump and government activity attempting to prop up the ailing industry.
Sibirtelecom, telecom provider in Russia’s Siberia, has posted a 1H 2009 Net Profit of 851 million Roubles.
Russian fixed line telecom, CenterTelecom, has posted a 1H 2009 Net Profit of 2.93 billion Roubles.
Leading Russian pharmaceutical producer Veropharm, has posted a 1H 2009 Net Profit of $18.1 million under IFRS.
Leading Russian industrial railway transporter, Transgarant, has posted a FY 2008 Net Profit of 160.5 million Roubles under IFRS.
Russian mobile operator, Mobile TeleSystems (MTS), has posted a 2Q 2009 net income of $563 million under U.S. GAAP.
Corporate results can be confusing, but when looking at results from Russian companies it is important to know what accounting standard is being used.
Russia’s largest sea port operator, Novorossiysk Commercial Sea Port (NCSP), has posted a 9M 2009 Net Profit of $208 million under IFRS.
Published: 01 September, 2009, 11:35
The leading Russian pharmaceutical company, Pharmstandard has posted a 1H 2009 Net Profit of 2.59 billion Roubles under IFRS.